Manufacturing Project Scope
Raysun Biopharma presents its manufacturing scope for qualified B2B project evaluation across peptide APIs and sterile peptide finished dosage forms, growth hormone APIs and finished dosage forms, and sterile oligonucleotide formulations. Potential collaboration pathways include API-to-FDF development, formulation and finished dosage form development, process validation and scale-up pathways, and CDMO/CMO project services.
Each inquiry is reviewed against the proposed dosage format, development stage, technical and documentation requirements, target market, regulatory pathway, and intended manufacturing arrangements. Facility and equipment fit, validation requirements, manufacturing readiness, project timing and commercial scope are confirmed case by case through formal project review. This page does not represent installed or qualified equipment, validated capacity, routine production, GMP certification, regulatory approval, product registration, stock or guaranteed supply.
Vientiane Project Progress - 26 August 2026
This construction-stage visual update documents ongoing structural and site work at Raysun's Vientiane project. The images and videos below show work in progress and do not indicate that the facility is operational, validated or authorized for routine GMP manufacturing.
Construction Update
Latest Site Images
